CMND
Clearmind Medicine Inc. Common Shares
NASDAQ: CMND · HEALTHCARE · BIOTECHNOLOGY
$0.70
-5.61% today
Updated 2026-04-29
Market cap
$1.94M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-24.12
Dividend yield
—
52W range
$1 – $52
Volume
5.8M
WallStSmart proprietary scores
26
out of 100
Grade: F
Strong Sell
Investment rating
4.3
Growth
C5.0
Quality
C+3.0
Profitability
D5.0
Valuation
C+—/9
Piotroski F-Score
—
—
Altman Z-Score
—
—
Industry rank
—
View all highly rated stocks (75+) →206 stocks currently score above 75
Price targets
Analyst target
$—
—
12-Month target
—
—
Intrinsic (DCF)
—
Margin of safety
—
Price chart
X-Ray snapshot
Strengths
Insufficient data
Risks
- Thin margins at 0.00%
- Negative free cash flow $-2.08M
Key financials
Revenue Net Income Free Cash Flow
| Metric | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Net income | $-9.93M | $-11.85M | $-7.31M | $-3.86M | $-3.85M |
| EPS | — | — | — | — | $-24.12 |
| Free cash flow | $-5.06M | $-6.30M | $-6.76M | $-4.73M | $-2.08M |
| Profit margin | — | — | — | — | — |
Peer comparison
Smart narrative
Clearmind Medicine Inc. Common Shares trades at $0.70. Our Smart Value Score of 26/100 indicates the stock is weak.
Frequently asked questions
What is Clearmind Medicine Inc. Common Shares's stock price?
Clearmind Medicine Inc. Common Shares (CMND) trades at $0.70.
Is Clearmind Medicine Inc. Common Shares overvalued?
Smart Value Score 26/100 (Grade F, Strong Sell).
What is the price target of Clearmind Medicine Inc. Common Shares (CMND)?
The analyst target price is $—, representing NaN% downside from the current price of $0.70.
Company info
SectorHEALTHCARE
IndustryBIOTECHNOLOGY
CountryUSA
ExchangeNASDAQ
CurrencyUSD
Quick metrics
P/S ratio—
ROE-119.70%
Beta-1.03
50D MA$0.99
200D MA$18.79
Shares out0.00B
Float0.00B
Short ratio—
Avg volume5.8M
Performance
1 week—
1 month—
3 months—
YTD—
1 year—
3 years—
5 years—